{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T03:01:55Z","timestamp":1780282915154,"version":"3.54.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.oftale.2026.502508","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:37:51Z","timestamp":1774283871000},"page":"502508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tocilizumab and azathioprine in the management of refractory macular edema associated with Beh\u00e7et's disease: clinical experience"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9836-7477","authenticated-orcid":false,"given":"F.J.","family":"Barroso P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5621-6631","authenticated-orcid":false,"given":"P.","family":"Ba\u00f1eros Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6420-6533","authenticated-orcid":false,"given":"C.","family":"De la Cruz Tapiador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.oftale.2026.502508_bib0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/1744666X.2023.2193687","article-title":"Non-anti TNF\u03b1 biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review","volume":"19","author":"Bitossi","year":"2023","journal-title":"Expert Rev Clin Immunol."},{"issue":"6","key":"10.1016\/j.oftale.2026.502508_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.oftal.2014.03.016","article-title":"Early treatment with infliximab in bilateral occlusive vasculitis as a presenting manifestation of Beh\u00e7et\u2019 disease","volume":"90","author":"Ba\u00f1eros-Rojas","year":"2015","journal-title":"Arch Soc Esp Oftalmol."},{"issue":"7","key":"10.1016\/j.oftale.2026.502508_bib0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3899\/jrheum.221106","article-title":"Tocilizumab in Beh\u00e7et disease: a multicenter study of 30 patients","volume":"50","author":"Khitri","year":"2023","journal-title":"J Rheumatol."},{"issue":"5","key":"10.1016\/j.oftale.2026.502508_bib0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ophtha.2021.11.013","article-title":"Anti-tumor necrosis factor \u03b1 versus tocilizumab in the treatment of refractory uveitic macular edema: a multicenter study from the French uveitis network","volume":"129","author":"Leclercq","year":"2022","journal-title":"Ophthalmology."},{"issue":"6","key":"10.1016\/j.oftale.2026.502508_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-021-01011-z","article-title":"Advances in the treatment of Behcet\u2019s disease","volume":"23","author":"Alibaz-Oner","year":"2021","journal-title":"Curr Rheumatol Rep."},{"issue":"8","key":"10.1016\/j.oftale.2026.502508_bib0030","first-page":"1461","article-title":"Beh\u00e7et\u2019s syndrome: one year in review 2022","volume":"40","author":"Hatemi","year":"2022","journal-title":"Clin Exp Rheumatol."},{"issue":"1","key":"10.1016\/j.oftale.2026.502508_bib0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.sjopt.2016.12.004","article-title":"Successful treatment of Beh\u00e7et\u2019s uveitis with Tocilizumab","volume":"31","author":"Alokaily","year":"2017","journal-title":"Saudi J Ophthalmol."},{"key":"10.1016\/j.oftale.2026.502508_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152153","article-title":"Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet\u2019s disease. Multicenter study of 49 patients","volume":"58","author":"Barroso-Garc\u00eda","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.oftale.2026.502508_bib0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.46497\/ArchRheumatol.2024.11049","article-title":"New and future perspectives in Beh\u00e7et\u2019s syndrome","volume":"39","author":"Sulu","year":"2024","journal-title":"Arch Rheumatol."},{"issue":"1","key":"10.1016\/j.oftale.2026.502508_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/sjopt.sjopt_228_24","article-title":"Beh\u00e7et syndrome with eye involvement","volume":"39","author":"Ucar","year":"2025","journal-title":"Saudi J Ophthalmol."}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426000824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579426000824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T02:42:27Z","timestamp":1780281747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579426000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2173579426000824"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502508","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab and azathioprine in the management of refractory macular edema associated with Beh\u00e7et's disease: clinical experience","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2026.502508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2026.502508","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502508"}}